目次

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Poliomyelitis - Overview
Poliomyelitis - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Poliomyelitis - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Poliomyelitis - Companies Involved in Therapeutics Development
Beijing Minhai Biotechnology Co Ltd
Beijing Tiantan Biological Products Co Ltd
Bharat Biotech Ltd
Biken Co Ltd
Biological E Ltd
Biological Mimetics Inc
Boryung Pharmaceutical Co Ltd
CanSino Biologics Inc
Grifols SA
Helix Biogen Institute
Intravacc BV
Johnson & Johnson
KM Biologics Co Ltd
LG Chem Ltd
Micron Biomedical Inc
Nanolek
Panacea Biotec Ltd
Serum Institute of India Pvt Ltd
Shantha Biotechnics Pvt Ltd
Statera Biopharma Inc
Vaxxas Inc
Wuhan Institute of Biological Products Co Ltd
Poliomyelitis - Drug Profiles
(diphtheria + Haemophilus influenzae [serotype B] + hepatitis B + meningococcal [serotype C] + pertussis (whole cell) + poliomyelitis + tetanus) (heptavalent) vaccine - Drug Profile
Product Description
Mechanism Of Action
(diphtheria + haemophilus influenzae [serotype B] + hepatitis B + pertussis (whole cell) + poliomyelitis + tetanus) (hexavalent) vaccine - Drug Profile
Product Description
Mechanism Of Action
(diphtheria + haemophilus influenzae [serotype B] + hepatitis B + pertussis (whole cell) + poliomyelitis + tetanus) (hexavalent) vaccine - Drug Profile
Product Description
Mechanism Of Action
(diphtheria + Haemophilus influenzae [serotype B] + pertussis (whole cell) + polio + tetanus)(pentavalent) vaccine - Drug Profile
Product Description
Mechanism Of Action
(diphtheria + tetanus + pertussis (acellular) + poliomyelitis) vaccine - Drug Profile
Product Description
Mechanism Of Action
(diphtheria + tetanus + pertussis (acellular) + poliomyelitis) vaccine - Drug Profile
Product Description
Mechanism Of Action
(diphtheria + tetanus + pertussis + poliomyelitis + haemophilus influenzae [serotype B]) vaccine - Drug Profile
Product Description
Mechanism Of Action
BK-1310 - Drug Profile
Product Description
Mechanism Of Action
CSB-017 - Drug Profile
Product Description
Mechanism Of Action
immune globulin (human) - Drug Profile
Product Description
Mechanism Of Action
JNJ-2348 - Drug Profile
Product Description
Mechanism Of Action
KD-2396 - Drug Profile
Product Description
Mechanism Of Action
KD-370 - Drug Profile
Product Description
Mechanism Of Action
LBVC - Drug Profile
Product Description
Mechanism Of Action
LBVD - Drug Profile
Product Description
Mechanism Of Action
polio (trivalent) vaccine - Drug Profile
Product Description
Mechanism Of Action
polio [serotype 1] vaccine - Drug Profile
Product Description
Mechanism Of Action
polio [serotype 2] vaccine - Drug Profile
Product Description
Mechanism Of Action
polio [serotype 2] vaccine 1 - Drug Profile
Product Description
Mechanism Of Action
polio [serotype 3] (monovalent) vaccine - Drug Profile
Product Description
Mechanism Of Action
polio [serotype 3] vaccine - Drug Profile
Product Description
Mechanism Of Action
polio [serotype 3] vaccine - Drug Profile
Product Description
Mechanism Of Action
polio [serotypes 1, 2, 3] vaccine - Drug Profile
Product Description
Mechanism Of Action
polio [strain Sabin] vaccine - Drug Profile
Product Description
Mechanism Of Action
polio [strain Sabin] vaccine - Drug Profile
Product Description
Mechanism Of Action
polio [strain Sabin] vaccine - Drug Profile
Product Description
Mechanism Of Action
polio [strain Sabin] vaccine - Drug Profile
Product Description
Mechanism Of Action
polio vaccine - Drug Profile
Product Description
Mechanism Of Action
polio vaccine - Drug Profile
Product Description
Mechanism Of Action
polio vaccine - Drug Profile
Product Description
Mechanism Of Action
polio vaccine - Drug Profile
Product Description
Mechanism Of Action
polio vaccine - Drug Profile
Product Description
Mechanism Of Action
polio vaccine - Drug Profile
Product Description
Mechanism Of Action
polio vaccine 2 - Drug Profile
Product Description
Mechanism Of Action
poliomyelitis (trivalent) vaccine - Drug Profile
Product Description
Mechanism Of Action
poliomyelitis [sabin] (vero cell) vaccine - Drug Profile
Product Description
Mechanism Of Action
poliomyelitis [serotype PV3] (virus like particles) vaccine - Drug Profile
Product Description
Mechanism Of Action
poliomyelitis vaccine - Drug Profile
Product Description
Mechanism Of Action
poliomyelitis vaccine - Drug Profile
Product Description
Mechanism Of Action
poliomyelitis vaccine + rotavirus vaccine - Drug Profile
Product Description
Mechanism Of Action
SA-702 - Drug Profile
Product Description
Mechanism Of Action
Poliomyelitis - Dormant Projects
Poliomyelitis - Discontinued Products
Poliomyelitis - Product Development Milestones
Featured News & Press Releases
Jun 09, 2022: Sinovac Biotech receives WHO prequalification for polio vaccine
Apr 12, 2022: Pertussis, Diphtheria, Tetanus, Polio, Hib vaccine filed in Japan: BIKEN/Mitsubishi
Apr 11, 2022: Notification of manufacturing and marketing approval application for pertussis/diphtheria/tetanus/inactivated polio/Hib combined vaccine (BK1310/MT-2355)
Apr 11, 2022: Marketing authorization application of pertussis, diphtheria, tetanus, inactivated polio and Hib combined vaccine (BK1310/MT-2355)
Jul 20, 2021: Intravacc's inactivated polio vaccine, out licensed to Sinovac, receives market authorization in China
Dec 09, 2020: New polio vaccine against strain that threatens eradication is safe and generates immune response in adults, young children, and infants
Apr 23, 2020: AJ Vaccines secures WHO Prequalification for polio vaccine Picovax
Apr 16, 2019: Sinovac announces positive results from Phase III trial Of a Sabin Strain-Based Inactivated Polio Vaccine (sIPV) published in the journal of Infectiou
Mar 11, 2019: LG Chem gets $33.4 mil. from Gates Foundation for vaccine development
May 21, 2018: A single-injection vaccine for the polio virus
Apr 19, 2018: Sinovac Announces Preliminary Results of Phase III Trial on sIPV
Dec 10, 2015: Sinovac Obtains Clinical Trial Approval for Sabin-IPV Candidate
Sep 16, 2014: Vaxxas initiates research project on advancing next generation technology for polio vaccine delivery
Oct 31, 2012: Statens Serum Institut receives a grant of $158,739 from Bill & Melinda Gates Foundation
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Poliomyelitis, 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Companies, 2022 (Contd..1)
Number of Products under Development by Universities/Institutes, 2022
Products under Development by Companies, 2022
Products under Development by Companies, 2022 (Contd..1)
Products under Development by Universities/Institutes, 2022
Number of Products by Stage and Target, 2022
Number of Products by Stage and Mechanism of Action, 2022
Number of Products by Stage and Route of Administration, 2022
Number of Products by Stage and Molecule Type, 2022
Poliomyelitis - Pipeline by Beijing Minhai Biotechnology Co Ltd, 2022
Poliomyelitis - Pipeline by Beijing Tiantan Biological Products Co Ltd, 2022
Poliomyelitis - Pipeline by Bharat Biotech Ltd, 2022
Poliomyelitis - Pipeline by Biken Co Ltd, 2022
Poliomyelitis - Pipeline by Biological E Ltd, 2022
Poliomyelitis - Pipeline by Biological Mimetics Inc, 2022
Poliomyelitis - Pipeline by Boryung Pharmaceutical Co Ltd, 2022
Poliomyelitis - Pipeline by CanSino Biologics Inc, 2022
Poliomyelitis - Pipeline by Grifols SA, 2022
Poliomyelitis - Pipeline by Helix Biogen Institute, 2022
Poliomyelitis - Pipeline by Intravacc BV, 2022
Poliomyelitis - Pipeline by Johnson & Johnson, 2022
Poliomyelitis - Pipeline by KM Biologics Co Ltd, 2022
Poliomyelitis - Pipeline by LG Chem Ltd, 2022
Poliomyelitis - Pipeline by Micron Biomedical Inc, 2022
Poliomyelitis - Pipeline by Nanolek, 2022
Poliomyelitis - Pipeline by Panacea Biotec Ltd, 2022
Poliomyelitis - Pipeline by Serum Institute of India Pvt Ltd, 2022
Poliomyelitis - Pipeline by Shantha Biotechnics Pvt Ltd, 2022
Poliomyelitis - Pipeline by Statera Biopharma Inc, 2022
Poliomyelitis - Pipeline by Vaxxas Inc, 2022
Poliomyelitis - Pipeline by Wuhan Institute of Biological Products Co Ltd, 2022
Poliomyelitis - Dormant Projects, 2022
Poliomyelitis - Dormant Projects, 2022 (Contd..1)
Poliomyelitis - Discontinued Products, 2022

List of Figures
Number of Products under Development for Poliomyelitis, 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Number of Products by Top 10 Targets, 2022
Number of Products by Stage and Top 10 Targets, 2022
Number of Products by Stage and Top 10 Mechanism of Actions, 2022
Number of Products by Top 10 Routes of Administration, 2022
Number of Products by Stage and Top 10 Routes of Administration, 2022
Number of Products by Top 10 Molecule Types, 2022
Number of Products by Stage and Top 10 Molecule Types, 2022